Truist raised the firm’s price target on Astronics (ATRO) to $23 from $17 and keeps a Hold rating on the shares after its Q4 earnings. The company’s results beat on the top and bottom line and the aerospace segment put up the highest operating margins in over 10 years despite ongoing aircraft production related challenges, the analyst tells investors in a research note. Astronics’ Test segment remains challenged however and continued to undergo restructuring and appears to be highly dependent on the Army TS-4549T program to drive growth, Truist adds.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ATRO: